Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Kernicterus in the 21st century: frequently asked questions

Journal of Perinatology volume 29, pages S20–S24 (2009)Cite this article

Abstract

Acute kernicterus remains a clinical emergency and its delayed management represents an easily preventable neonatal brain injury. Yet, practitioners encounter recurrent questions regarding the risk and timing of bilirubin-related neurotoxicity. These include the following: does bilirubin damage the brain of healthy infants? Is there a re-emergence of kernicterus in the United States? Was kernicterus previously prevented in the United States? What was the public health impact of 1994 American Academy of Pediatrics Guidelines? What is the current incidence of kernicterus and severe neonatal hyperbilirubinemia? What is the estimated risk of kernicterus in infants with excessive hyperbilirubinemia? Is there a specific bilirubin threshold total serum bilirubin (TSB) value for neurotoxicity? Are there sequelae of severe or prolonged moderate hyperbilirubinemia in the absence of recognized acute bilirubin encephalopathy? Can we define a bilirubin level that is safe in newborns? We address these questions in the context of available data and evidence, and estimate the current risk of chronic kernicterus is about one in seven in infants with TSB >30 mg per 100 ml (513 μmol l−1).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

Article 16 February 2023

Evdokia Dimitriadis, Daniel L. Rolnik, … Ellen Menkhorst

References

  1. Bhutani VK, Johnson LH, Keren R . Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr Clin North Am 2004; 51 (4): 843–861.

    Article  PubMed  Google Scholar 

  2. Bhutani VK, Johnson LH, Maisels MJ, Newman TB, Phibbs C, Stark AR et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004; 24 (10): 650–662.

    Article  PubMed  Google Scholar 

  3. American Academy of Pediatrics, Provisional Committee for Quality Improvement. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994; 94: 558–565.

    Google Scholar 

  4. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia, Maisels MJ, Baltz RD, Bhutani VK, Newman TB, Palmer H, Rosenfeld W et al. Clinical Practice Guideline: management of hyperbilirubinemia in the newborn infant 35 weeks of gestation. Pediatrics 2004; 114: 297–316. Available at http://www.aappolicy.aappublications.org/cgi/content/full/pediatrics; 114/1/297.

    Article  Google Scholar 

  5. Ip S, Chung M, Kulig J, O'Brien R, Sege R, Glicken S, et al., Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004; 114: e130–e153.

    Article  PubMed  Google Scholar 

  6. Newman TB, Maisels MJ . Bilirubin and brain damage: what do we do now? Pediatrics 1989; 83 (6): 1062–1065.

    CAS  PubMed  Google Scholar 

  7. Newman TB, Maisels MJ . Does hyperbilirubinemia damage the brain of healthy full-term infants? Clin Perinatol 1990; 17 (2): 331–358.

    Article  CAS  PubMed  Google Scholar 

  8. Newman TB, Maisels MJ . Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992; 89 (5 Part 1): 809–818.

    CAS  PubMed  Google Scholar 

  9. Penn AA, Enzmann DR, Hahn JS, Stevenson DK . Kernicterus in a full term infant. Pediatrics 1994; 93: 1003–1006.

    CAS  PubMed  Google Scholar 

  10. Johnson LH, Brown AK, Bhutani VK . System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002; 140: 396–403.

    Article  PubMed  Google Scholar 

  11. Philip AG . The evolution of neonatology. Pediatr Res 2005; 58: 799–815.

    Article  PubMed  Google Scholar 

  12. Bhutani VK, Johnson L . Kernicterus: lessons for the future from a current tragedy. NeoReviews 2003; 4: 30–32.

    Article  Google Scholar 

  13. Bhutani VK, Maisels MJ, Stark AR, Buonocore G . Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants ⩾35 weeks gestation. Neonatology 2008; 94 (1): 63–67.

    Article  PubMed  Google Scholar 

  14. Ebbesen F . Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr 2000; 89: 1213–1217.

    Article  CAS  PubMed  Google Scholar 

  15. Ebbesen F, Andersson C, Verder H, Grytter C, Pedersen-Bjergaard L, Petersen JR et al. Extreme hyperbilirubinaemia in term and near-term infants in Denmark. Acta Paediatr 2005; 94: 59–64.

    Article  CAS  PubMed  Google Scholar 

  16. Manning DJ, Maxwell MJ, Todd PJ, Platt MJ . Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the United Kingdom and Ireland. Arch Dis Child Fetal Neonatal Ed. Online publication. 0.1136/adc.2006.105361. Available at http://fn.bmj.com/cgi/rapidpdf/adc.2006.105361v1Ebb.

  17. Sgro M, Campbell D, Shah V . Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006; 175: 587–590.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Bhutani VK, Johnson LH, Schwoebel A, Gennaro S . A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs 2006; 35: 444–455.

    Article  PubMed  Google Scholar 

  19. Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, Wu YW, Hudes ES et al. Jaundice and Infant Feeding Study Team: outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 2006; 354: 1889–1900.

    Article  CAS  PubMed  Google Scholar 

  20. Newman TB, Xiong B, Gonzales VM, Escobar GJ . Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 2000; 154: 1140–1147.

    Article  CAS  PubMed  Google Scholar 

  21. Kaplan M, Bromiker R, Schimmel MS, Algur N, Hammerman C . Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience. J Pediatr 2007; 150: 412–417.

    Article  CAS  PubMed  Google Scholar 

  22. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD . The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics 2006; 117: e855–e862.

    Article  PubMed  Google Scholar 

  23. Bhutani VK, Rodriguez M . HCA Perinatal Safety Initiative Kernicterus Taskforce. Recent epidemiologic indices of severe hyperbilirubinemia and kernicterus for a diverse multi-state newborn population in USA. http://www.abstracts2view.com/pasall/.E-PAS2005:1225.

  24. Newman TB, Liljestrand P, Escobar GJ . Infants with bilirubin levels of 30 mg/dl or more in a large managed care organization. Pediatrics 2003; 111 (6 Part 1): 1303–1311.

    Article  PubMed  Google Scholar 

  25. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM . Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006; 117: 474–485.

    Article  PubMed  Google Scholar 

  26. Newman TB, Klebanoff MA . Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics 1993; 92(5): 651–657.

    CAS  PubMed  Google Scholar 

  27. Bhutani VK . Neonatal hyperbilirubinemia and the potential risk of subtle neurological dysfunction. Pediatr Res 2001; 50(6):679–680.

    Article  CAS  PubMed  Google Scholar 

  28. Soorani-Lunsing I, Woltil HA, Hadders-Algra M . Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain? Pediatr Res 2001; 50 (6): 701–705.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine and Lucile Packard Children's Hospital, Stanford, CA, USA

    V K Bhutani

  2. Pennsylvania Center for Kernicterus, Philadelphia, PA, USA

    L Johnson

Authors
  1. V K Bhutani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V K Bhutani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhutani, V., Johnson, L. Kernicterus in the 21st century: frequently asked questions. J Perinatol 29 (Suppl 1), S20–S24 (2009). https://doi.org/10.1038/jp.2008.212

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2008.212

Keywords

This article is cited by

Search

Advanced search

Quick links